BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18708356)

  • 21. Positively charged amino acids flanking a sumoylation consensus tetramer on the 110kDa tri-snRNP component SART1 enhance sumoylation efficiency.
    Schimmel J; Balog CI; Deelder AM; Drijfhout JW; Hensbergen PJ; Vertegaal AC
    J Proteomics; 2010 Jun; 73(8):1523-34. PubMed ID: 20346425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.
    Gareau JR; Lima CD
    Nat Rev Mol Cell Biol; 2010 Dec; 11(12):861-71. PubMed ID: 21102611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9.
    Tatham MH; Jaffray E; Vaughan OA; Desterro JM; Botting CH; Naismith JH; Hay RT
    J Biol Chem; 2001 Sep; 276(38):35368-74. PubMed ID: 11451954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-native Conformers of Cystic Fibrosis Transmembrane Conductance Regulator NBD1 Are Recognized by Hsp27 and Conjugated to SUMO-2 for Degradation.
    Gong X; Ahner A; Roldan A; Lukacs GL; Thibodeau PH; Frizzell RA
    J Biol Chem; 2016 Jan; 291(4):2004-2017. PubMed ID: 26627832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The N-terminal internal region of BLM is required for the formation of dots/rod-like structures which are associated with SUMO-1.
    Suzuki H; Seki M; Kobayashi T; Kawabe Yi ; Kaneko H; Kondo N; Harata M; Mizuno S; Masuko T; Enomoto T
    Biochem Biophys Res Commun; 2001 Aug; 286(2):322-7. PubMed ID: 11500040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates.
    Gocke CB; Yu H; Kang J
    J Biol Chem; 2005 Feb; 280(6):5004-12. PubMed ID: 15561718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural attributes in the conjugation of ubiquitin, SUMO and RUB to protein substrates.
    Goettsch S; Bayer P
    Front Biosci; 2002 Aug; 7():a148-62. PubMed ID: 12133807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs).
    Wu YC; Roark AA; Bian XL; Wilson VG
    Virology; 2008 Sep; 378(2):329-38. PubMed ID: 18619639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics.
    Vertegaal AC; Andersen JS; Ogg SC; Hay RT; Mann M; Lamond AI
    Mol Cell Proteomics; 2006 Dec; 5(12):2298-310. PubMed ID: 17000644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and Characterization of SUMO-SIM Interactions.
    Husnjak K; Keiten-Schmitz J; Müller S
    Methods Mol Biol; 2016; 1475():79-98. PubMed ID: 27631799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction.
    Cooper HJ; Tatham MH; Jaffray E; Heath JK; Lam TT; Marshall AG; Hay RT
    Anal Chem; 2005 Oct; 77(19):6310-9. PubMed ID: 16194093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small Ubiquitin-like Modifier Alters IFN Response.
    Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
    J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CTCF insulator protein is posttranslationally modified by SUMO.
    MacPherson MJ; Beatty LG; Zhou W; Du M; Sadowski PD
    Mol Cell Biol; 2009 Feb; 29(3):714-25. PubMed ID: 19029252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification of cardiac transcription factor Gata6 by SUMO.
    Chen H; Sun W; Zhu J; Yuan H; Chu M; Wen B
    Biochimie; 2020 Mar; 170():212-218. PubMed ID: 32017966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
    Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
    J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-nuclear trafficking of the BLM helicase to DNA damage-induced foci is regulated by SUMO modification.
    Eladad S; Ye TZ; Hu P; Leversha M; Beresten S; Matunis MJ; Ellis NA
    Hum Mol Genet; 2005 May; 14(10):1351-65. PubMed ID: 15829507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of protein SUMOylation sites by mass spectrometry using combined microwave-assisted aspartic acid cleavage and tryptic digestion.
    Osula O; Swatkoski S; Cotter RJ
    J Mass Spectrom; 2012 May; 47(5):644-54. PubMed ID: 22576878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25.
    Meulmeester E; Kunze M; Hsiao HH; Urlaub H; Melchior F
    Mol Cell; 2008 Jun; 30(5):610-9. PubMed ID: 18538659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1.
    Kim YH; Choi CY; Kim Y
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12350-5. PubMed ID: 10535925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted identification of SUMOylation sites in human proteins using affinity enrichment and paralog-specific reporter ions.
    Lamoliatte F; Bonneil E; Durette C; Caron-Lizotte O; Wildemann D; Zerweck J; Wenshuk H; Thibault P
    Mol Cell Proteomics; 2013 Sep; 12(9):2536-50. PubMed ID: 23750026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.